Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Plantation FL (Clinical Trial # 39212)

You are viewing an inactive listing

This listing is not currently available. You can either be notified when it becomes available or browse nearby active listings below.

Click here to view additional nearby listings or search by keyword.

Clinical Trial 39212

Plantation, FL 33322

Summary:

Phase 2b Open-Label study of Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Qualified Participants Must:

• 18 and older
• Received at least 2 but no more than 5 previous systemic regimens
• Previously treated, pathologically confired de novo DLBCL

Qualified Participants May Receive:

Study medication will be provided at no cost to participant

Research Site Profile

Nearby listings:

Click here to view additional nearby listings or search by keyword.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.

Services for Research Sites

National Recruitment Services

News And Information